Symbiotec Pharmalab IPO Subscription
UpcomingUpdated 23 August 2026, 6:32 AM IST· Mainboard
Symbiotec Pharmalab IPO subscription status opens on 24 August 2026. Live QIB, NII, Retail, SHNI, and BHNI numbers will appear once bidding starts.
Allotment date is 28 August 2026. Listing date on NSE and BSE is 1 September 2026.
Symbiotec Pharmalab IPO Day-wise Subscription
Daily QIB, NII, Retail, and overall subscription as bids come in
Day-wise subscription will appear here once bidding starts on 24 August 2026.
Symbiotec Pharmalab IPO Allotment Chances
Retail, SHNI, and BHNI chances based on application subscription
Symbiotec Pharmalab IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
Allotment chances will show here once subscription data is live.
Check the Symbiotec Pharmalab IPO Allotment Status page from 28 August 2026 for your result.
Symbiotec Pharmalab IPO Subscription by Amount
Category-wise amount, applications, and shares once live
Detailed subscription tables will appear here once bidding data is available from 24 August 2026.
Symbiotec Pharmalab IPO GMP After Subscription
GMP for Symbiotec Pharmalab IPO stands at Rs 410.00 today, giving an estimated listing price of Rs 1,398.00 per share.
The GMP has moved up from Rs 220.00 on 19 Aug 2026 to Rs 410.00 on 23 Aug 2026.
Track live GMP on the Symbiotec Pharmalab IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Symbiotec Pharmalab IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 24 August 2026 |
| IPO Close Date | 27 August 2026 |
| Allotment Date | 28 August 2026 |
| Refund Initiation | 29 August 2026 |
| Share Credit to Demat | 29 August 2026 |
| Listing Date | 1 September 2026 |
| Minimum Investment | Rs 14,820.00 |
| Lot Size | 15 shares |
About Symbiotec Pharmalab IPO
Symbiotec Pharmalab Limited (incorporated in 2002) is an established research-driven pharmaceutical and biotechnology company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), particularly corticosteroids and steroidal-hormone APIs, alongside contract development and manufacturing (CDMO) services and complex injectables. The company operates industrial-scale manufacturing facilities at Rau and Pithampur SEZ in Madhya Pradesh with US FDA, EU-GMP, and WHO-GMP approvals, alongside newly commissioned biomanufacturing facilities in Ujjain and dedicated complex injectables facilities in Mhow. As of March 31, 2026, Symbiotec served over 200 customers across more than 40 countries, holding 43 US FDA Drug Master Files (DMFs) and 23 European Certificates of Suitability (CEPs).
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
Retail - Retail Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
Symbiotec Pharmalab IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Symbiotec Pharmalab IPO Details
Issue size, price, financials, and company info
Symbiotec Pharmalab IPO GMP
Live grey market premium and listing estimate
Symbiotec Pharmalab IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Symbiotec Pharmalab IPO Allotment
Allotment date, chances, and check by PAN
Symbiotec Pharmalab IPO Review
SWOT, strengths, risks, and IPO review
Symbiotec Pharmalab IPO FAQ
Common questions on dates, GMP, and allotment
Symbiotec Pharmalab IPO Registrar
Registrar website and how to check allotment
Symbiotec Pharmalab IPO Timeline
Open, close, allotment, and listing dates
Symbiotec Pharmalab IPO News
Updates, blogs, and latest IPO news
Symbiotec Pharmalab IPO Subscription FAQs
What is Symbiotec Pharmalab IPO subscription status today?
Symbiotec Pharmalab IPO overall subscription is - today (by shares). QIB N/A, NII N/A, Retail N/A. Live updates from 24 August 2026 to 27 August 2026.
What is the overall subscription of Symbiotec Pharmalab IPO?
Symbiotec Pharmalab IPO overall subscription data is not available yet. Figures update once bidding starts on 24 August 2026.
What is Symbiotec Pharmalab IPO QIB subscription?
QIB subscription for Symbiotec Pharmalab IPO will appear here once institutional bids are recorded.
What is Symbiotec Pharmalab IPO Retail subscription?
Retail subscription for Symbiotec Pharmalab IPO is not live yet.
What is Symbiotec Pharmalab IPO NII, SHNI, and BHNI subscription?
NII, SHNI, and BHNI subscription for Symbiotec Pharmalab IPO will update during the bidding window.
What are Symbiotec Pharmalab IPO retail allotment chances?
Symbiotec Pharmalab IPO retail allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.
What are Symbiotec Pharmalab IPO SHNI allotment chances?
Symbiotec Pharmalab IPO SHNI allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.
What are Symbiotec Pharmalab IPO BHNI allotment chances?
Symbiotec Pharmalab IPO BHNI allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.
When is Symbiotec Pharmalab IPO allotment date?
Symbiotec Pharmalab IPO allotment date is 28 August 2026. Check Symbiotec Pharmalab IPO Allotment Status on IPOwiz from that day using your PAN.
When does Symbiotec Pharmalab IPO subscription close?
Symbiotec Pharmalab IPO subscription is open until 27 August 2026. Apply before the last day closes.
What is Symbiotec Pharmalab IPO GMP today?
Symbiotec Pharmalab IPO GMP is ₹410 today (+41.50% over issue price ₹988). See live GMP on the Symbiotec Pharmalab IPO GMP Today page.
What is Symbiotec Pharmalab IPO issue price and lot size?
Symbiotec Pharmalab IPO issue price is ₹988 per share. Lot size is 15 shares. Minimum investment is ₹14,820 per lot. Issue size: ₹1,757.00 Cr.
When is Symbiotec Pharmalab IPO listing date?
Symbiotec Pharmalab IPO listing date is 1 September 2026 on NSE and BSE. Allotment is on 28 August 2026.
How does subscription affect Symbiotec Pharmalab IPO allotment?
In Symbiotec Pharmalab IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At - overall, competition is moderate.
For allotment results from 28 August 2026, visit the Symbiotec Pharmalab IPO Allotment Status page. For listing day updates on 1 September 2026, download the IPOwiz App.
Sources
We match Symbiotec Pharmalab IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.